Kazumi Yoshida

Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy

Shigeru Yutani, Akira Yamada, Kazumi Yoshida et al. · Vaccine · 2007 · 47 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Phase I clinical study of a peptide vaccination for hepatitis C virus‐infected patients with different human leukocyte antigen‐class I‐A alleles

Shigeru Yutani, Nobukazu Komatsu, Shigeki Shichijo et al. · Cancer Science · 2009 · 43 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis

Stephan A. Vorburger, Abujiang Pataer, Kazumi Yoshida et al. · Oncogene · 2002 · 40 citations

Life Sciences, Cell Biology, Molecular Biology +11

Combination Therapy of Personalized Peptide Vaccination and Low-Dose Estramustine Phosphate for Metastatic Hormone Refractory Prostate Cancer Patients: An Analysis of Prognostic Factors in the Treatment

Masanori Noguchi, Takashi Mine, Akira Yamada et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2006 · 36 citations · Full text

Medicine, Immunology, Oncology +17

The Mitochondrial Apoptosis-Inducing Factor Plays a Role in E2F-1?Induced Apoptosis in Human Colon Cancer Cells

Stephan A. Vorburger, Abujiang Pataer, Kazumi Yoshida et al. · Annals of Surgical Oncology · 2003 · 17 citations

Life Sciences, Cell Biology, Oncology +13